WallStSmart

Goldman Sachs Group Inc (GS)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 3350% more annual revenue ($2.33T vs $67.57B). GS leads profitability with a 31.0% profit margin vs 17.3%. NMR appears more attractively valued with a PEG of 0.82. NMR earns a higher WallStSmart Score of 84/100 (A-).

GS

Exceptional Buy

83

out of 100

Grade: A-

Growth: 10.0Profit: 8.0Value: 6.3Quality: 3.0
Piotroski: 4/9Altman Z: 0.14

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GS6 strengths · Avg: 9.7/10
Market CapQuality
$299.67B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
31.0%10/10

Keeps 31 of every $100 in revenue as profit

Operating MarginProfitability
42.2%10/10

Strong operational efficiency at 42.2%

Revenue GrowthGrowth
42.5%10/10

Revenue surging 42.5% year-over-year

EPS GrowthGrowth
92.3%10/10

Earnings expanding 92.3% YoY

P/E RatioValuation
15.9x8/10

Attractively priced relative to earnings

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.2x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

GS2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.142/10

Distress zone — elevated risk

Debt/EquityHealth
6.041/10

Elevated debt levels

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : GS

The strongest argument for GS centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 31.0% and operating margin at 42.2%. Revenue growth of 42.5% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bear Case : GS

The primary concerns for GS are Altman Z-Score, Debt/Equity. Debt-to-equity of 6.04 is elevated, increasing financial risk.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Key Dynamics to Monitor

GS carries more volatility with a beta of 1.28 — expect wider price swings.

GS is growing revenue faster at 42.5% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 83/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Exceptional Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Goldman Sachs Group Inc

FINANCIAL SERVICES · CAPITAL MARKETS · USA

The Goldman Sachs Group, Inc., is an American multinational investment bank and financial services company headquartered in New York City. It offers services in investment management, securities, asset management, prime brokerage, and securities underwriting. It also provides investment banking to institutional investors.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?